Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

for (Select 19520905)

1.

Implementation of lung cancer screening: promises and hurdles.

Prosch H.

Transl Lung Cancer Res. 2014 Oct;3(5):286-90. doi: 10.3978/j.issn.2218-6751.2014.09.11. Review.

2.

Potential biomarkers for lung cancer screening.

Sozzi G, Boeri M.

Transl Lung Cancer Res. 2014 Jun;3(3):139-48. doi: 10.3978/j.issn.2218-6751.2014.06.04. Review.

3.

The lung cancer epidemic in Spanish women: an analysis of mortality rates over a 37-year period.

López-Campos JL, Ruiz-Ramos M, Calero C.

J Thorac Dis. 2014 Dec;6(12):1668-73. doi: 10.3978/j.issn.2072-1439.2014.10.28.

4.

Lung cancer screening: subsequent evidences of national lung screening trial.

Park YS.

Tuberc Respir Dis (Seoul). 2014 Aug;77(2):55-9. doi: 10.4046/trd.2014.77.2.55. Epub 2014 Aug 29. Review.

5.

Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers.

Hulbert A, Hooker CM, Keruly JC, Brown T, Horton K, Fishman E, Rodgers K, Lee B, Sam C, Tsai S, Weihe E, Pridham G, Drummond B, Merlo C, Geronimo M, Porter M, Cox S, Li D, Harline M, Teran M, Wrangle J, Mudge B, Taylor G, Kirk GD, Herman JG, Moore RD, Brown RH, Brock MV.

J Thorac Oncol. 2014 Jun;9(6):752-9. doi: 10.1097/JTO.0000000000000161.

6.

Predicted for greatness: 1994 molecule of the year--the DNA repair enzyme.

Berwick M.

Cancer Prev Res (Phila). 2014 Apr;7(4):375-7. doi: 10.1158/1940-6207.CAPR-14-0050. Epub 2014 Mar 20.

7.

Would screening for lung cancer benefit 75- to 84-year-old residents of the United States?

Varlotto JM, Decamp MM, Flickinger JC, Lake J, Recht A, Belani CP, Reed MF, Toth JW, Mackley HB, Sciamanna CN, Lipton A, Ali SM, Mahraj RP, Gilbert CR, Yao N.

Front Oncol. 2014 Mar 7;4:37. doi: 10.3389/fonc.2014.00037. eCollection 2014.

8.

Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom.

Duffy SW, Field JK, Allgood PC, Seigneurin A.

Br J Cancer. 2014 Apr 2;110(7):1834-40. doi: 10.1038/bjc.2014.63. Epub 2014 Feb 13.

9.

Lung cancer screening: from imaging to biomarker.

Xiang D, Zhang B, Doll D, Shen K, Kloecker G, Freter C.

Biomark Res. 2013 Jan 16;1(1):4. doi: 10.1186/2050-7771-1-4.

10.

Screening for lung cancer with low-dose computed tomography: a review of current status.

Marshall HM, Bowman RV, Yang IA, Fong KM, Berg CD.

J Thorac Dis. 2013 Oct;5 Suppl 5:S524-39. doi: 10.3978/j.issn.2072-1439.2013.09.06. Review.

11.

Lung cancer screening: past, present and future.

Finigan JH, Kern JA.

Clin Chest Med. 2013 Sep;34(3):365-71. doi: 10.1016/j.ccm.2013.03.004. Epub 2013 Jul 23. Review.

12.

Screening for lung cancer with low-dose computed tomography.

Miller AB.

Oncologist. 2013;18(8):897-9. doi: 10.1634/theoncologist.2013-0159. Epub 2013 Aug 5. No abstract available.

13.

Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.

Goulart BH, Ramsey SD.

Oncologist. 2013;18(8):941-6. doi: 10.1634/theoncologist.2013-0007. Epub 2013 Jul 19.

14.

Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.

Corley DA, Mehtani K, Quesenberry C, Zhao W, de Boer J, Weiss NS.

Gastroenterology. 2013 Aug;145(2):312-9.e1. doi: 10.1053/j.gastro.2013.05.004. Epub 2013 May 11.

15.

Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB.

Chest. 2013 May;143(5 Suppl):e78S-92S. doi: 10.1378/chest.12-2350. Review.

16.

American Cancer Society lung cancer screening guidelines.

Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YC, Sullivan DC, Travis W, Walter L, Wolf AM, Brawley OW, Smith RA.

CA Cancer J Clin. 2013 Mar-Apr;63(2):107-17. doi: 10.3322/caac.21172. Epub 2013 Jan 11. Review.

17.

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).

Couraud S, Cortot AB, Greillier L, Gounant V, Mennecier B, Girard N, Besse B, Brouchet L, Castelnau O, Frappé P, Ferretti GR, Guittet L, Khalil A, Lefebure P, Laurent F, Liebart S, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Trédaniel J, Lemarié E, Zalcman G, Barlési F, Milleron B; French lung cancer screening statement taskforce; groupe d'Oncologie de langue française.

Ann Oncol. 2013 Mar;24(3):586-97. doi: 10.1093/annonc/mds476. Epub 2012 Nov 7.

18.

The role and potential of imaging in COPD.

Washko GR.

Med Clin North Am. 2012 Jul;96(4):729-43. doi: 10.1016/j.mcna.2012.05.003. Review.

19.

CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort.

Greenberg AK, Lu F, Goldberg JD, Eylers E, Tsay JC, Yie TA, Naidich D, McGuinness G, Pass H, Tchou-Wong KM, Addrizzo-Harris D, Chachoua A, Crawford B, Rom WN.

PLoS One. 2012;7(7):e39403. doi: 10.1371/journal.pone.0039403. Epub 2012 Jul 2.

20.

Benefits and harms of CT screening for lung cancer: a systematic review.

Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC.

JAMA. 2012 Jun 13;307(22):2418-29. doi: 10.1001/jama.2012.5521. Review. Erratum in: JAMA. 2013 Jun 5;309(21):2212. JAMA. 2012 Oct 3;308(13):1324.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk